Antipsychotic Drug&#8217;s Weight Gain Tied to Lower Body Temp | Psych Central News

Trish Groves Health Communicator

Using the tools of science to improve social policy | Society | The Observer

guardian.co.uk — “When drugs are launched, we expect rigorous testing, so why don't we use science to help determine government policies, asks Mark Henderson” View full resource at guardian.co.uk

Most Recently Shared on May 13, 2012 at 7:44 am By:

Using the tools of science to improve social policy http://t.co/qRg4CSfG via @guardian <- pitch in, Twitter. I just did

OrganizedWisdom RA OW Health

New Drug for Rheumatoid Arthritis Favored by FDA Panel - Yahoo! News

news.yahoo.com — “From Yahoo! News: For those who have rheumatoid arthritis and are just not getting any benefits from their current treatment regimen, there could be hope on the horizon. A major drug company, Pfizer, has developed a new drug that has received FDA panel favor. This does not mean that the FDA will definitely approve it.” View full resource at news.yahoo.com

Most Recently Shared on May 12, 2012 at 7:44 am By:

New Drug for Rheumatoid Arthritis Favored by FDA Panel: For those who have rheumatoid arthritis and are just not... http://t.co/QmqUK6js

OrganizedWisdom RA OW Health

FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

pharmaceuticalonline.com — “Pfizer Inc. (NYSE:PFE) announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend” View full resource at pharmaceuticalonline.com

Most Recently Shared on May 12, 2012 at 7:07 am By:

FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severe... http://t.co/soPAIfWQ

OrganizedWisdom RA OW Health

Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug - Health News - redOrbit

redorbit.com — “An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.” View full resource at redorbit.com

Most Recently Shared on May 11, 2012 at 7:41 pm By:

Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug: Connie K. Ho for http://t.co/6eqBD5l3 An adv... http://t.co/d6SkusIQ

MedPage Today Health News

Medical News: Phone Calls Boost Drug Adherence After Stenting - in Meeting Coverage, SCAI from MedPage Today

medpagetoday.com — “Medical News: Phone Calls Boost Drug Adherence After Stenting - in Meeting Coverage, SCAI from MedPage Today” View full resource at medpagetoday.com

Most Recently Shared on May 11, 2012 at 7:01 pm By:

Phone Calls Boost Drug Adherence After #Stenting. #SCAI http://t.co/pzrP6QlH

Ear, Nose, and Throat OW Health

Parents Greatly Underestimate Children’s Secondhand Smoke Exposure | The Partnership

drugfree.org — “A drug abuse prevention, intervention, treatment and recovery resources to help parents and caregivers effectively address alcohol and drug abuse with their teens and young adults.” View full resource at drugfree.org

Most Recently Shared on May 11, 2012 at 6:54 pm By:

Parents Greatly Underestimate Children’s Secondhand Smoke Exposure: A new study finds parents greatly underestim... http://t.co/fJuzJFz1

Bosutinib Buyer Beware | Chemical & Engineering News

cen.acs.org — “Bosutinib Buyer Beware | Chemical & Engineering News” View full resource at cen.acs.org

Most Recently Shared on May 11, 2012 at 4:47 pm By:

C&EN Science Enthusiast

Buyer Beware: "Bad" bosutinib (an isomer) been going around. None to patients, Pfizer says. But damaging to research. http://t.co/XT4ORYCS

As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile... -- AMBLER, Pa., April 26, 2012 /PRNewswire/ --

prnewswire.com — “As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data. Survey Finds 85 Percent of Nurses Want to Use Smartphones to Access Current Drug Information.” View full resource at prnewswire.com

Most Recently Shared on May 11, 2012 at 4:05 pm By:

JGNJournal Medical Journal and Nursing

@lippincott @Wolters_Kluwer survey: #Nurses & #Nursing #Students Want Mobile Access to Credible Drug Data http://t.co/XrSQqrGd

MNT Drug Approvals Health News

HIV Prevention Pill Receives FDA Panel Support

medicalnewstoday.com — “On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people.” View full resource at medicalnewstoday.com

Most Recently Shared on May 11, 2012 at 3:05 pm By:

HIV Prevention Pill Receives FDA Panel Support http://t.co/qePK7BRk #regulatory

Diet Drug Wins Approval of F.D.A. Advisers - NYTimes.com

nytimes.com — “Government advisers recommended that the F.D.A. approve the weight-loss drug lorcaserin.” View full resource at nytimes.com

Most Recently Shared on May 11, 2012 at 2:00 pm By:

Mary Sue McAslan PharmD, Doctor, and Pharmacist

Diet Drug Wins Panel’s Approval http://t.co/rSJrN5Bj

FDA Panel Favors Arena Obesity Drug - WSJ.com

online.wsj.com — “A Food and Drug Administration advisory committee recommended the agency approve an Arena Pharmaceuticals drug to treat obesity, the second time this year advisors have backed a fat-fighting medication.” View full resource at online.wsj.com

Most Recently Shared on May 11, 2012 at 1:58 pm By:

William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor

FDA Panel Backs New Obesity Drug http://t.co/Gs9psNfr via @WSJ

Google's Brin Makes Strides on Parkinson's Cure - Businessweek

businessweek.com — “Sergey Brin, the 38-year-old co- founder of Google Inc. (GOOG), is making strides in his quest to find a cure for Parkinson’s, a progressive disease his DNA and family history suggest may afflict him as early as 10 years from now.” View full resource at businessweek.com

Most Recently Shared on May 11, 2012 at 1:23 pm By:

Matthew Herper

Trying again: @RobertLangreth profiles Sergey Brin and his work on Parkinson's. http://t.co/EuOQjp5N

AIDSmeds - Top Stories : Truvada Receives PrEP Approval Recommendation - by Tim Horn

aidsmeds.com — “In a series of votes by the U.S. Food and Drug Administration?s Antiviral Drugs Advisory Committee, Truvada (tenofovir plus emtricitabine) has been recommended for approval as the first prescription drug to prevent HIV among those at risk for the infection.” View full resource at aidsmeds.com

Most Recently Shared on May 11, 2012 at 1:06 pm By:

AIDSmeds Health News

Top Stories : #Truvada Receives #PrEP Approval Recommendation http://t.co/gsQT5TCi #Gilead $GILD #HIV #AIDS

F.D.A. Panel Backs Preventive Use of H.I.V. Drug Truvada - NYTimes.com

nytimes.com — “With 50,000 new H.I.V. cases each year in the United States, government advisers said Truvada, an antiviral medicine, should be approved for use in healthy people at high risk of infection.” View full resource at nytimes.com

Most Recently Shared on May 11, 2012 at 12:07 pm By:

elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist

FDA Advisory Panel Backs Preventive Use of HIV Drug - http://t.co/0ZD6U9HY